PetIQ Inc (PETQ)
16.53
+0.21
(+1.29%)
USD |
NASDAQ |
Apr 26, 16:00
16.52
-0.01
(-0.06%)
After-Hours: 20:00
PetIQ Debt to Equity Ratio: 2.018 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.018 |
| September 30, 2023 | 1.886 |
| June 30, 2023 | 1.921 |
| March 31, 2023 | 2.036 |
| December 31, 2022 | 2.153 |
| September 30, 2022 | 2.123 |
| June 30, 2022 | 1.733 |
| March 31, 2022 | 1.859 |
| December 31, 2021 | 1.807 |
| September 30, 2021 | 1.711 |
| June 30, 2021 | 1.744 |
| March 31, 2021 | 1.811 |
| December 31, 2020 | 1.866 |
| Date | Value |
|---|---|
| September 30, 2020 | 1.369 |
| June 30, 2020 | 1.121 |
| March 31, 2020 | 1.123 |
| December 31, 2019 | 0.9014 |
| September 30, 2019 | 0.9021 |
| June 30, 2019 | 0.3619 |
| March 31, 2019 | 0.439 |
| December 31, 2018 | 0.4276 |
| September 30, 2018 | 0.6215 |
| June 30, 2018 | 0.8237 |
| March 31, 2018 | 1.052 |
| December 31, 2017 | 0.2598 |
| September 30, 2017 | 0.2855 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3619
Minimum
Jun 2019
2.153
Maximum
Dec 2022
1.602
Average
1.807
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Dynavax Technologies Corp | 0.358 |
| Pacira BioSciences Inc | 0.6004 |
| Supernus Pharmaceuticals Inc | 0.00 |
| Esperion Therapeutics Inc | -0.5749 |
| Deciphera Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 868.23M |
| Total Liabilities (Quarterly) | 645.23M |
| Shareholders Equity (Quarterly) | 221.21M |
| Current Ratio | 2.273 |
| Net Debt Paydown Yield | 0.23% |